Jarle Kotsbak

Part of Svenska Handelsbanken AB, Handelsbanken Markets Norge is a Norwegian company that provides security brokerage services.

Sarsia Innovation AS invests in companies located in the northern part of Norway. Selected companies are from various sectors but they all are developing new concepts in their field. The fund is currently closed for new investments.

Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006.

Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway.

Med Storm Innovation AS develops bio sensor systems. It develops medical software solutions for analyzing skin conductance or emotional sweating for monitoring and detecting stress/pain and awakening on patients. The company was founded by Hanne Storm on December 22, 1998 and is headquartered in Oslo, Norway.

Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway.

Delante Health AS specializes in the manufacture of nutritional products. It engages in the production of products with vitamins and minerals. The firm's product platform Lipidfizz is a patented omega-3 drink powder delivered in individual servings. Its technology enables consumption of omega-3 and other polyunsaturated fatty acids in effervescent powders and tablets. The company was founded by Hans Robert Wahren and Bjørn Skjævestad in 2005 and is headquartered in Bekkestua, Norway.

Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway.

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Seafarm Solutions AS designs, produces, and sells goods and services to the fishing industry. It manufactures machines and equipment for the fish farmers. The company was founded by Claus Mikael Søberg and Morten Aga on August 10, 2000 and is headquartered in Vaksdal, Norway.

Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway.